Elsie Grace

Injection Site Reactions in the Federal Adverse Event Reporting System (FAERS) Post-Marketing Database Vary Among Biologics Approved to Treat Moderate-To-Severe Psoriasis

Elsie Grace, Orin M. Goldblum, L. Renda et al. · Dermatology and Therapy · 2019 · 30 citations · Full text

Pharmacy, Dermatology, Pharmacology +16

Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials

Atul Deodhar, Andrew Blauvelt, Mark Lebwohl et al. · Arthritis Research & Therapy · 2024 · 25 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Pregnancy outcomes in patients with psoriasis, psoriatic arthritis, or axial spondyloarthritis receiving ixekizumab

Alexander Egeberg, Lars Iversen, Alexa B. Kimball et al. · Journal of Dermatological Treatment · 2021 · 20 citations · Full text

Medicine, Immunology, Obstetrics +14

Quality of life in reflux and dyspepsia. Development and psychometric documentation of a disease-specific questionnaire (QOLRAD)

Ingela Wiklund, Ola Junghard, Elsie Grace et al. · Gastroenterology · 1998 · 17 citations

Medicine, Internal Medicine, Gastroenterology +13

Disease response and patient-reported outcomes among initiators of ixekizumab

Mona Shahriari, Ryan W. Harrison, Russel Burge et al. · Journal of Dermatological Treatment · 2020 · 10 citations

Medicine, Dermatology, Pharmacotherapy +13